Bjorklund, A. & Dunnett, S. B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30, 194â202 (2007).
Clarke, R. L. et al. Compounds affecting the central nervous system. 4. 3 Beta-phenyltropane-2-carboxylic esters and analogs. J. Med. Chem. 16, 1260â1267 (1973).
Janowsky, A., Tosh, D. K., Eshleman, A. J. & Jacobson, K. A. Rigid adenine nucleoside derivatives as novel modulators of the human sodium symporters for dopamine and norepinephrine. J. Pharm. Expt. Therapeutics 357, 24â35 (2016).
Norregaard, L., Fredericksen, D., Nielsen, E. O. & Gether, U. Delineation of an endogenous zinc-binding site in the human dopamine transporter. EMBO J. 17, 4266â4273 (1998).
Speranza, L., di Porzio, U., Viggiano, D., de Donato, A. & Volpicelli, F. Dopamine: the neuromodulator of long-term synaptic plasticity, reward and movement control. Cells 10, 735 (2021).
Bucolo, C., Leggio, G. M., Drago, F. & Salomone, S. Dopamine outside the brain: the eye, cardiovascular system and endocrine pancreas. Pharmacol. Ther. 203, 107392 (2019).
Kandel, E. R., Schwartz, J. H.and Jessel, T. M. Principles of Neural Science (Appleton and Lange, 1991).
Goetz, C. G. The history of Parkinsonâs disease: early clinical descriptions and neurological therapies. Cold Spring Harb. Perspect. Med. 1, a008862 (2011).
Klein, M. O. et al. Dopamine: functions, signaling, and association with neurological diseases. Cell. Mol. Neurobiol. 39, 31â59 (2019).
Groom, M. J. & Cortese, S. Current pharmacological treatments for ADHD. Curr. Top. Behav. Neurosci. 57, 19â50 (2022).
Newman, A. H., Ku, T., Jordan, C. J., Bonifazi, A. & Xi, Z. X. New drugs, old targets: tweaking the dopamine system to treat psychostimulant use disorders. Annu. Rev. Pharmacol. Toxicol. 61, 609â628 (2021).
Rudnick, G., Krämer, R., Blakely, R. D., Murphy, D. L. & Verrey, F. The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction. Pflugers Arch. 466, 25â42 (2014).
Mitchell, P. A general theory of membrane transport from studies of bacteria. Nature 180, 134â136 (1957).
Schmidt, S. G. et al. The dopamine transporter antiports potassium to increase the uptake of dopamine. Nat. Commun. 13, 2446 (2022).
Frederickson, C. J. et al. Synaptic release of zinc from brain slices: factors governing release, imaging, and accurate calculation of concentration. J. Neurosci. Methods 154, 19â29 (2006).
Tosh, D. K. et al. Scaffold repurposing of nucleosides (adenosine receptor agonists): enhanced activity at the human dopamine and norepinephrine sodium symporters. J. Med. Chem. 60, 3109â3123 (2017).
Aggarwal, S. et al. Identification of a novel allosteric modulator of the human dopamine transporter. ACS Chem. Neurosci. 10, 3718â3730 (2019).
Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85â90 (2013).
Wang, K. H., Penmatsa, A. & Gouaux, E. Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322â327 (2015).
Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine. Nat. Struct. Mol. Biol. 22, 506â508 (2015).
Navratna, V., Tosh, D. K., Jacobson, K. A. & Gouaux, E. Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation. PLoS ONE 13, e0200085 (2018).
Kristensen, A. S. et al. SLC6 neurotransmitter transporters: structure, function and regulation. Pharmacol. Rev. 63, 585â640 (2011).
Aggarwal, S. & Mortensen, O. V. Discovery and development of monoamine transporter ligands. Adv. Neurobiol. 30, 101â129 (2023).
Jayaraman, K. et al. SLC6 transporter oligomerization. J. Neurochem. 157, 919â929 (2021).
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+/Clâ dependent neurotransmitter transporters. Nature 437, 215â223 (2005).
Hong, W. C. & Amara, S. G. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J. Biol. Chem. 285, 32616â32626 (2010).
Jones, K. T., Zhen, J. & Reith, M. E. Importance of cholesterol in dopamine transporter function. J. Neurochem. 123, 700â715 (2012).
Zeppelin, T., Ladefoged, L. K., Sinning, S., Periole, X. & Schiott, B. A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition. PLoS Comput. Biol. 14, e1005907 (2018).
Coleman, J. A., Green, E. M. & Gouaux, E. X-ray structures and mechanism of the human serotonin transporter. Nature 532, 334â339 (2016).
Li, L. B. et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J. Biol. Chem. 279, 21012â21020 (2004).
Reeves, P. J., Callewaert, N., Contreras, R. & Khorana, H. G. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl Acad. Sci. USA 99, 13419â13424 (2002).
Kuhar, M. J. et al. Studies of selected phenyltropanes at monoamine transporters. Drug Alcohol Depend. 56, 9â15 (1999).
Wong, E. H. et al. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Biol. Psychiatry 47, 818â829 (2000).
Andersen, J., Ringsted, K. B., Bang-Andersen, B., Stromgaard, K. & Kristensen, A. S. Binding site residues control inhibitor selectivity in the human norepinephrine transporter but not in the human dopamine transporter. Sci. Rep. 5, 15650 (2015).
Owens, M. J., Knight, D. L. & Nemeroff, C. B. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol. Psychiatry 50, 345â350 (2001).
Gu, H., Wall, S. C. & Rudnick, G. Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124â7130 (1994).
Wang, H. et al. Structural basis for action by diverse antidepressants on biogenic amine transporters. Nature 503, 141â145 (2013).
Krishnamurthy, H., Piscitelli, C. L. & Gouaux, E. Unlocking the molecular secrets of sodium-coupled transporters. Nature 459, 347â355 (2009).
Kitayama, S. et al. Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc. Natl Acad. Sci. USA 89, 7782â7785 (1992).
Bismuth, Y., Kavanaugh, M. P. & Kanner, B. I. Tyrosine 140 of the gamma-aminobutyric acid transporter GAT-1 plays a critical role in neurotransmitter recognition. J. Biol. Chem. 272, 16096â16102 (1997).
Yang, D. & Gouaux, E. Illumination of serotonin transporter mechanism and role of the allosteric site. Sci. Adv. 7, eabl3857 (2021).
Yang, D., Zhao, Z., Tajkhorshid, E. & Gouaux, E. Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants. Proc. Natl Acad. Sci. USA 120, e2304602120 (2023).
Yamashita, A., Singh, S. K., Kawate, T., Jin, Y. & Gouaux, E. Crystal structure of a bacterial homologue of Na+/Clâ-dependent neurotransmitter transporters. Nature 437, 215â223 (2005).
Plenge, P. et al. The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter. Nat. Commun. 12, 5063 (2021).
Aniksztejn, L., Charton, G. & Ben-Ari, Y. Selective release of endogenous zinc from the hippocampal mossy fibers in situ. Brain Res. 404, 58â64 (1987).
Stockner, T. et al. Mutational analysis of the high-affinity zinc binding site validates a refined human dopamine transporter homology model. PLoS Comput. Biol. 9, e1002909 (2013).
Loland, C. J., Norregaard, L. & Gether, U. Defining proximity relationships in the tertiary structure of the dopamine transporter. Identification of a conserved glutamic acid as a third coordinate in the endogenous Zn2+-binding site. J. Biol. Chem. 274, 36928â36934 (1999).
Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574â2585 (2014).
Kubala, M. H., Kovtun, O., Alexandrov, K. & Collins, B. M. Structural and thermodynamic analysis of the GFP:GFP-nanobody complex. Protein Sci. 19, 2389â2401 (2010).
Guo, H. et al. Electron-event representation data enable efficient cryoEM file storage with full preservation of spatial and temporal resolution. IUCrJ 7, 860â869 (2020).
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290â296 (2017).
Wright, N. J. et al. Methotrexate recognition by the human reduced folate carrier SLC19A1. Nature 609, 1056â1062 (2022).
Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214â1221 (2020).
Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583â589 (2021).
Pettersen, E. F. et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 30, 70â82 (2021).
Casanal, A., Lohkamp, B. & Emsley, P. Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data. Protein Sci. 29, 1069â1078 (2020).
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D 75, 861â877 (2019).
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D 74, 531â544 (2018).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12â21 (2010).
Gucwa, M. et al. CMM-An enhanced platform for interactive validation of metal binding sites. Protein Sci. 32, e4525 (2023).
Amunts, A. et al. Structure of the yeast mitochondrial large ribosomal subunit. Science 343, 1485â1489 (2014).
Alvadia, C. et al. Cryo-EM structures and functional characterization of the murine lipid scramblase TMEM16F. eLife 8, e44365 (2019).
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296âW303 (2018).
Quick, M. & Javitch, J. A. Monitoring the function of membrane transport proteins in detergent-solubilized form. Proc. Natl Acad. Sci. USA 104, 3603â3608 (2007).
Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351â367 (2004).
Sastry, G. M., Adzhigirey, M., Day, T., Annabhimoju, R. & Sherman, W. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J. Comput. Aided Mol. Des. 27, 221â234 (2013).
Gumbart, J., Trabuco, L. G., Schreiner, E., Villa, E. & Schulten, K. Regulation of the protein-conducting channel by a bound ribosome. Structure 17, 1453â1464 (2009).
Zhang, L. & Hermans, J. Hydrophilicity of cavities in proteins. Proteins 24, 433â438 (1996).
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33â38 (1996).
Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859â1865 (2008).
Lomize, M. A., Pogozheva, I. D., Joo, H., Mosberg, H. I. & Lomize, A. L. OPM database and PPM web server: resources for positioning of proteins in membranes. Nucleic Acids Res. 40, D370âD376 (2012). (Database issue).
Tian, C. et al. ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. 16, 528â552 (2020).
Dickson, C. J., Walker, R. C. & Gould, I. R. Lipid21: complex lipid membrane simulations with AMBER. J. Chem. Theory Comput. 18, 1726â1736 (2022).
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926â935 (1983).
Li, P., Song, L. F. & Merz, K. M. Jr Parameterization of highly charged metal ions using the 12-6-4 LJ-type nonbonded model in explicit water. J. Phys. Chem. B 119, 883â895 (2015).
Yoo, J. & Aksimentiev, A. New tricks for old dogs: improving the accuracy of biomolecular force fields by pair-specific corrections to non-bonded interactions. Phys. Chem. Chem. Phys. 20, 8432â8449 (2018).
Lu, C. et al. OPLS4: improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291â4300 (2021).
Shelley, J. C. et al. Epik: a software program for pKa prediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681â691 (2007).
Wang, J., Wolf, R. M., Caldwell, J. W., Kollman, P. A. & Case, D. A. Development and testing of a general amber force field. J. Comput. Chem. 25, 1157â1174 (2004).
He, X., Man, V. H., Yang, W., Lee, T. S. & Wang, J. A fast and high-quality charge model for the next generation general AMBER force field. J. Chem. Phys. 153, 114502 (2020).
Case, D. A. et al. AMBER 2020 (University of California, San Francisco, 2020).
Pastor, R. W., Brooks, B. R. & Szabo, A. An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol. Phys. 65, 1409â1419 (1988).
Aqvist, J., Wennerstrom, P., Nervall, M., Bjelic, S. & Brandsdal, B. O. Molecular dynamics simulations of water and biomolecules with a Monte Carlo constant pressure algorithm. Chem. Phys. Lett. 384, 288â294 (2004).
Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: an N.log(N) method for Ewald sums in large systems. J. Chem. Phys. 98, 10089â10092 (1993).
Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Physics 23, 327â341 (1977).
Case, D. A. et al. AmberTools. J. Chem. Inf. Model. 63, 6183â6191 (2023).
Roe, D. R. & Cheatham, T. E. 3rd PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084â3095 (2013).
Sk, M. F. & Tajkhorshid, E. Raw data for: Structure of the human dopamine transporter and mechanisms of allosteric inhibition. Zenodo https://doi.org/10.5281/zenodo.11391488 (2024).
